We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Celsion

News List

Celsion Announces Formation of Vaccine Advisory Board americanpharmaceuticalreview
February 22, 2021
Celsion announced the formation of a Vaccine Advisory Board and the appointment of its first two members.
Celsion Initiates Phase II OVATION 2 Study of GEN-1 in Advanced Ovarian Cancer americanpharmaceuticalreview
August 03, 2020
Celsion announced the randomization of the first two patients in the Phase II portion of the Phase I/II OVATION 2 Study with GEN-1 in advanced ovarian cancer.
Celsion’s GEN-1 Immunotherapy Receives Orphan Drug Designation from EMA americanpharmaceuticalreview
March 24, 2020
Celsion announced the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has recommended that GEN-1 be designated ...